Continuous CI monitoring in multiple sclerosis Helped shape promotional strategies in line with shift in market trend from platform agents to high-efficacy therapies (orals and IVs) Analysed the impact of Ocrevus launch on oral agents and high-efficacy MAbs Business Impact Client Leading Pharma Company Therapy Area Neurology CASE STUDY www.course5i.com Project objectives To design and deliver a customized CI program for continuous monitoring and report key competitor activities for both marketed products and pipeline molecules To derive actionable insights by analysing information gathered from multiple data sources Scope Geography: Global Disease segment: Relapsing and progressive forms of multiple sclerosis Treatment landscape: Disease-modifying agents to control relapses an

Join for free to read